Sarah Denny

Title: Innovations and Contributions of Inventor Sarah Denny

Introduction

Sarah Denny is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in gene editing and regulation. With a total of 11 patents to her name, her work has the potential to impact various medical applications.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Compositions and methods for the targeting of PCSK9." This patent describes gene repressor systems that include fusion proteins, such as those comprising a DNA binding domain like a TALE, zinc finger, or catalytically-dead CRISPR protein, along with guide nucleic acid (gRNA). These systems are designed to repress the transcription of the PCSK9 gene, which plays a crucial role in cholesterol regulation. Another notable patent is for "Engineered guide scaffolds," which details engineered Class 2 Type V nucleases and guide RNAs that are useful for editing target nucleic acids. This invention outlines methods for creating and utilizing these variants to modify nucleic acids effectively.

Career Highlights

Sarah Denny has established herself as a key figure in her field through her innovative research and development efforts. Her work at Scribe Therapeutics Inc. has positioned her at the forefront of gene editing technology.

Collaborations

She collaborates with talented individuals such as Benjamin Oakes and Sean Higgins, contributing to a dynamic and innovative work environment.

Conclusion

In summary, Sarah Denny's contributions to biotechnology through her patents and collaborative efforts highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in gene editing and regulation.